
GRAL vs CDNA
$GRAL vs $CDNA head to head: price, market cap, valuation, dividend, free float, relative volume and how actively each trades. The bigger value in the size rows is bolded. Tap either ticker for its live chart, full ownership breakdown and real-time alerts.
GRAL vs CDNA: trend, levels and the market
One year to 2026-11-20, against the S&P 500 (+4.7%). Split-adjusted daily closes.
- ·CDNA has the cleaner trend, above both its 50- and 200-day averages, where GRAL is above one and below the other.
- ·Both beat the market over the past year: GRAL +6.1% and CDNA +307%, against the S&P 500 at +4.7%.
- ·GRAL sits closer to its support, 9.6% above it at $93.52, while CDNA is 32.5% above its own at $47.13.
Support and resistance are daily prices the stock has turned at three or more times, within 35% of the price. The loading zone is the nearby price where the heaviest volume traded. These describe where a stock has been, not where it will go. Not investment advice.
GRAL vs CDNA: the quick read
- ·GRAL is the larger company by market cap ($4.46B vs $3.68B).
- ·CDNA has been more active on our scanner (180 vs 171 alerts in 30 days).
- ·GRAL has the smaller float (44.2M vs 52.2M), which tends to mean sharper, more volatile moves.
- ·Both are services-medical laboratories names, so this is a like-for-like comparison and sector news tends to move them together.
- ·Both stay busy on our scanner, 180 and 171 unusual-volume alerts over 30 days, so neither is the quiet one here.
- ·They are closely matched in size, within 21% of each other on market cap, which makes the rest of this table the interesting part.
Objective differences only. Not investment advice.
Watching GRAL or CDNA? Get each morning’s movers by email
Free daily email of the top plays and unusual-volume alerts our scanner flags. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Frequently asked questions
Everything you need to know comparing GRAL and CDNA on TheDesperateTrader.
- Is GRAL or CDNA the better stock?
- "Better" depends on your goal, and these two are not alike. GRAL is the larger company by market cap ($4.46B vs $3.68B). CDNA has been more active on our scanner (180 vs 171 alerts in 30 days). GRAL has the smaller float (44.2M vs 52.2M), which tends to mean sharper, more volatile moves. Those are the measured differences, not a recommendation, and nothing here is investment advice.
- What is the difference between GRAL and CDNA?
- The differences that matter: they are similar in size ($4.46B vs $3.68B); they trade at very different share prices ($103.49 vs $69.79); GRAL sits at 50% of its 52-week range against 72% for CDNA; our scanner flagged GRAL 171 times in the last 30 days against 180 for CDNA. Everything above is measured from the latest completed session and SEC filings.
- Which of GRAL and CDNA is more active right now?
- Right now GRAL is at about 0.8x its normal volume and CDNA is at about 0.6x, so GRAL is the one drawing unusual attention today. Relative volume (RVOL) compares a stock's volume to its own recent average, so it reads the same way for a megacap and a microcap and is the quickest way to tell which of two similar names is actually in play.
- Is GRAL or CDNA in the stronger trend?
- GRAL is below its 50-day average of $123.32 and above its 200-day average of $79.27; CDNA is above its 50-day average of $68.60 and above its 200-day average of $38.04. CDNA leads 5 of the 5 measures on this page (1 year, vs S&P 500, 3 months, 1 month, trend). A trend is where a stock has been, not a forecast, and nothing here is investment advice.
- Is this comparison data live?
- Prices and % changes are anchored to the latest completed session and split-adjusted, so a reverse split never shows as a fake move. Float is estimated from SEC filings and refreshed as new filings publish.
Trading GRAL or CDNA? Get real-time unusual-volume alerts the moment either one moves, free.
No card · 5 premium daysMore GRAL and CDNA comparisons
Same sector, similar size. These are the peers each one is usually weighed against.
Explore the market
Free, live market tools. No account required to look.